Designing Drug Development Programs for Reimbursement Success
Download the guide to learn how model-informed drug development, QSP, and MBMA help align with…
Certara2026 年 5 月 7 日
Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome
Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome
A newly approved RNA interference (RNAi) therapy lowers harmful triglyceride (TG) levels in patients with…
Certara2026 年 5 月 7 日
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
This study evaluated how the leukemia drug ziftomenib behaves in the body and whether different…
Certara2026 年 5 月 7 日
Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies
Population pharmacokinetic (PopPK) and exposure-response modeling were used to support the clinical development of nemtabrutinib,…
Certara2026 年 5 月 7 日
Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint
Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…
Certara2026 年 5 月 6 日
GxP compliance in the cloud: What IT teams need to rethink
Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…
Certara2026 年 5 月 4 日
From models to impact: What QSPC 2026 revealed about the future of drug development
Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…
Certara2026 年 4 月 28 日
ADC dose optimization: Applying model-informed strategies in development
Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…
Certara2026 年 4 月 22 日
Mean residence time (MRT): Understanding how long drug molecules stay in the body
JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026 年 4 月 16 日 When I first began learning about pharmacokinetics (PK), I was often…
Certara2026 年 4 月 16 日
